172 related articles for article (PubMed ID: 17523306)
21. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
22. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
23. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
24. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
[TBL] [Abstract][Full Text] [Related]
25. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
26. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
27. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C.
Benini F; Pigozzi MG; Baisini O; Romanini L; Ahmed H; Pozzi A; Ricci C; Lanzini A
J Gastroenterol Hepatol; 2007 Oct; 22(10):1621-6. PubMed ID: 17845689
[TBL] [Abstract][Full Text] [Related]
28. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
[TBL] [Abstract][Full Text] [Related]
29. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
[TBL] [Abstract][Full Text] [Related]
30. The serum soluble HLA-DR antigens as a predictive marker of the response to interferon-alpha treatment in patients with chronic hepatitis C.
Hosoi K; Hagihara M; Kagawa T; Watanabe N; Matsuzaki S
Tokai J Exp Clin Med; 2000 Oct; 25(3):117-24. PubMed ID: 11368209
[TBL] [Abstract][Full Text] [Related]
31. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
32. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
33. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
Meier V; Mihm S; Ramadori G
J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
[TBL] [Abstract][Full Text] [Related]
36. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
[TBL] [Abstract][Full Text] [Related]
37. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
38. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis.
Lüth S; Herkel J; Kanzler S; Frenzel C; Galle PR; Dienes HP; Schramm C; Lohse AW
J Clin Gastroenterol; 2008 Sep; 42(8):926-30. PubMed ID: 18645526
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.
Watson MW; Jaksic A; Price P; Cheng W; McInerney M; French MA; Fisher S; Lee S; Flexman JP
J Infect Dis; 2003 Nov; 188(10):1533-6. PubMed ID: 14624379
[TBL] [Abstract][Full Text] [Related]
40. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]